Method for producing self-assembled objects comprising fullerene nanotubes and compositions thereof
This invention relates generally to a method for producing self-assembled objects comprising fullerene nanotubes and compositions thereof. In one embodiment, the present invention involves a three-dimensional structure of derivatized fullerene nanotubes that spontaneously form. It includes several components having multiple derivatives brought together to assemble into the three-dimensional structure. In another embodiment, objects may be obtained by bonding functionally-specific agents (FSAs) to groups of nanotubes, enabling them to form into structures. The bond selectivity of FSAs allow selected nanotubes of a particular size or kind to assemble together and inhibit the assembling of unselected nanotubes that may also be present.
1. A three-dimensional structure that self-assembles from derivatized fullerene nanotubes comprising: a plurality of multifunctional fullerene nanotubes assembled into said three-dimensional structure.
2. The three-dimensional structure of claim 1 , wherein said fullerene nanotubes have multifunctional derivatives on their end caps.
3. The three-dimensional structure of claim 1 , wherein said fullerene nanotubes have multifunctional derivatives at multiple locations on said fullerene nanotubes.
4. The three-dimensional structure of claim 1 , wherein said fullerene nanotubes are assembled as a result of van der Waals attractions.
5. A three-dimensional structure of claim 1 , which has electromagnetic properties.
6. The three-dimensional structure of claim 5 , wherein said electromagnetic properties are determined by a functionally-specific agent.
7. A three-dimensional structure of claim 1 , which is symmetrical.
8. A three-dimensional structure of claim 1 , which is not symmetrical.
9. A three-dimensional structure of claim 1 , which has biological properties.
10. A three-dimensional structure of claim 9 , which operates as a catalyst for biochemical reactions.
11. A three-dimensional structure of claim 9 , which interacts with living tissue.
12. A three-dimensional structure of claim 9 , which serves as an agent for interaction with functions of a biological system.
13. A structure formed by the process comprising: (a) providing fullerene nanotubes derivatized with at least one functionally-specific agent; (b) exposing the derivatized nanotubes to another moiety for which the functionally-specific agent has an attraction; and (c) recovering assemblies formed by the derivatized nanotubes.
14. The structure of claim 13 wherein the fullerene nanotubes are derivatized with at least two different functionally-specific agents.
15. The structure of claim 13 wherein the functionally-specific agents are derivatized on the ends of the fullerene nanotubes.
16. The structure of claim 13 wherein the structure is symmetrical.
17. The structure of claim 13 wherein the structure is not symmetrical.
18. The structure of claim 13 wherein the structure is three-dimensional.
19. The structure of claim 13 wherein the structure is an electrical circuit.
20. The structure of claim 13 wherein the structure is a diode junction.
21. The structure of claim 13 wherein the structure is a capacitor.
22. The structure of claim 21 wherein the capacitor is a memory element.
23. The structure of claim 13 wherein the structure is an inductor.
24. The structure of claim 13 wherein the structure is a pass element.
25. The structure of claim 13 wherein the structure is a switch.
26. The structure of claim 13 wherein the structure is an antenna.
27. The structure of claim 13 wherein the structure is an antenna array.
28. The structure of claim 13 wherein the structure is capable of interaction with an optical fiber.
29. The structure of claim 13 wherein the structure is a catalyst.
30. The structure of claim 13 wherein the structure is a sorbent for specific chemicals.
31. The structure of claim 13 wherein the structure is resistant to attack by specific chemicals.
32. The structure of claim 13 wherein the structure is resistant to corrosion.
33. The structure of claim 13 wherein the structure is a pharmaceutical substance.
34. The structure of claim 13 wherein the structure is an agent capable of enabling growth of biological systems.
35. The structure of claim 13 wherein the structure is capable of interacting with biological systems.